Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenske

Showing results (1011-1020 of 1,142) with videos related to

Pageof 115
Sort By:
Blood|September 23, 2011
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphomaTodd A Fehniger, Sarah Larson, Kathryn Trinkaus, et al.
The Journal of Investigative Dermatology|January 11, 2013
Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skinMichelle R Iannacone, Tarik Gheit, Tim Waterboer, et al.
Cancer|November 14, 2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphomaDaniel J Landsburg, Adam M Petrich, Jeremy S Abramson, et al.
Intensive Care Medicine|February 25, 2014
Clinical practice guideline on diagnosis and treatment of hyponatraemiaGoce Spasovski, Raymond Vanholder, Bruno Allolio, et al.
EMBO Molecular Medicine|June 2, 2016
A novel thermoregulatory role for PDE10A in mouse and human adipocytesMohammed K Hankir, Mathias Kranz, Thorsten Gnad, et al.
The Lancet. Oncology|February 25, 2018
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human studyHoward A Burris, Ian W Flinn, Manish R Patel, et al.
Hematological Oncology|January 10, 2017
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" studyNarendranath Epperla, Mehdi Hamadani, Amanda F Cashen, et al.
Bone Marrow Transplantation|January 4, 2024
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantationSaurabh Chhabra, James H Jerkins, Kathleen Monahan, et al.
The British Journal of Dermatology|November 16, 2018
Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulationS S Hampras, M Tommasino, Y Zhao, et al.
Microbiome|February 9, 2020
Gastric bypass surgery in a rat model alters the community structure and functional composition of the intestinal microbiota independently of weight lossSven-Bastiaan Haange, Nico Jehmlich, Ute Krügel, et al.
Pageof 115

Showing results (1011-1020 of 1,142) with videos related to

Sort By:
Pageof 115
Blood|September 23, 2011
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphomaTodd A Fehniger, Sarah Larson, Kathryn Trinkaus, et al.
The Journal of Investigative Dermatology|January 11, 2013
Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skinMichelle R Iannacone, Tarik Gheit, Tim Waterboer, et al.
Cancer|November 14, 2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphomaDaniel J Landsburg, Adam M Petrich, Jeremy S Abramson, et al.
Intensive Care Medicine|February 25, 2014
Clinical practice guideline on diagnosis and treatment of hyponatraemiaGoce Spasovski, Raymond Vanholder, Bruno Allolio, et al.
EMBO Molecular Medicine|June 2, 2016
A novel thermoregulatory role for PDE10A in mouse and human adipocytesMohammed K Hankir, Mathias Kranz, Thorsten Gnad, et al.
The Lancet. Oncology|February 25, 2018
Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human studyHoward A Burris, Ian W Flinn, Manish R Patel, et al.
Hematological Oncology|January 10, 2017
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" studyNarendranath Epperla, Mehdi Hamadani, Amanda F Cashen, et al.
Bone Marrow Transplantation|January 4, 2024
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantationSaurabh Chhabra, James H Jerkins, Kathleen Monahan, et al.
The British Journal of Dermatology|November 16, 2018
Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulationS S Hampras, M Tommasino, Y Zhao, et al.
Microbiome|February 9, 2020
Gastric bypass surgery in a rat model alters the community structure and functional composition of the intestinal microbiota independently of weight lossSven-Bastiaan Haange, Nico Jehmlich, Ute Krügel, et al.
Pageof 115